Final report of the amended safety assessment of Glyceryl Laurate, Glyceryl Laurate SE, Glyceryl Laurate/Oleate, Glyceryl Adipate, Glyceryl Alginate, Glyceryl Arachidate, Glyceryl Arachidonate, Glyceryl Behenate, Glyceryl Caprate, Glyceryl Caprylate, Glyceryl Caprylate/Caprate (see abstract)

International Journal of Toxicology

Volumn 23, Issue SUPPL. 2, 2004, Pages 55-94

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ESTER; GLYCERATE LINOLEATE; GLYCEROL ARACHIDONATE; GLYCEROL BEHENATE; GLYCEROL DERIVATIVE; GLYCEROL LACTATE; GLYCEROL LAURATE; GLYCEROL LINOLEATE; GLYCEROL LINOLENATE; GLYCEROL MYRISTATE; GLYCEROL OLEATE; GLYCEROL STEARATE; GLYCERYL ALGINATE; GLYCERYL ARACHIDATE; GLYCERYL CAPRATE; GLYCERYL CITRATE; GLYCERYL COCOATE; GLYCERYL COLLAGENATE; GLYCERYL ELAIDATE; GLYCERYL ERUCATE; GLYCERYL HYDROGENATED ROSINATE; GLYCERYL HYDROGENATED SOYATE; GLYCERYL HYDROXYSTEARATE; GLYCERYL ISOPALMITATE; GLYCERYL ISOSTEARATE; GLYCERYL ISOTRIDECANOATE; GLYCERYL LANOLATE; GYLCERYL PALMITOLEATE; OCTANOIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLERGIC REACTION; AMES TEST; ANIMAL CELL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; CHRONIC DRUG ADMINISTRATION; COSMETIC INDUSTRY; DRUG PENETRATION; ERYTHEMA; ERYTHROCYTE; FEMALE; HEMOLYSIS; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PATCH TEST; RABBIT; RAT; REVIEW; RISK ASSESSMENT; SHEEP; SKIN ABSORPTION; SKIN IRRITATION;

ANIMALS; CONSUMER PRODUCT SAFETY; COSMETICS; ESTERS; GLYCERIDES; HUMANS; TOXICITY TESTS;

ANIMALIA; ORYCTOLAGUS CUNICULUS; OVIS ARIES;

EID: 5444220706     PISSN: 10915818     EISSN: None     Source Type: Journal    
DOI: 10.1080/10915810490499064     Document Type: Review

References (103)

1. American Conference of Governmental Industrial Hygienists (ACGIH). 1991. Threshold limit values for chemical substances and physical agents in the workroom environment with intended changes for 1990-1991. Cincinnati, OH: American Conference of Governmental Industrial Hygienists.
2. Andersen, F. A. 1993. Final report on the safety assessment of arachidonic acid. J. Am. Coll. Toxicol 12(5):481-559.
3. Aungst, B. J., N. J. Rogers, and E. Shefter. 1986. Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int. J. Pharm. 33:225-234.
4. 2
5. 2
6. 2
7. 2
8. 2
9. Blobe, G. C., L. M. Obeid, and Y. A. Hannun. 1994. Regulation of protein kinase C and role in cancer biology. Cancer Metastasis Rev. 13:411-431.
10. 2
11. 2
12. Budavari, S. 1989. The Merck index. An encyclopedia of chemicals, drugs, and biologicals, 983-984, 1530-1531, 1534. Rahway, NJ Merck & Co., Inc.
13. 2
14. Chaibi, A., L. H. Ababouch, and F. F. Busta. 1996a. Inhibition of bacterial spores and vegetative cells by glycerides. J. Food Protection 59:716-722.
15. Chaibi, A., L. H. Ababouch, and F. F. Busta. 1996b. Inhibition by monoglycerides of L-alanine-triggered Bacillus cereus. J. Food Protection 59:832-837.
16. 2
17. 2
18. 2
19. 2
20. 2
21. 2 Unpublished data submitted by CTFA June 2000.
22. 2
23. 2
24. 2
25. 2
26. 2
27. 2
28. 2
29. 2
30. 2
31. 2
32. 2
33. Eagle, E., and C. E. Poling. 1955. The oral toxicity and pathology of polyoxyethylene derivatives in rats and hamsters. Food Res. 21:348-361.
34. Elder, R. L., ed. 1982. Final report on the safety assessment of glyceryl stearate and glyceryl stearate/SE. J. Am. Coll. Toxicol. 1:169-192.
35. Elder, R. L., ed. 1986. Final report on the safety assessment of glyceryl oleate. J. Am. Coll. Toxicol 5:391-413.
36. European Economic Community (EEC). 2001. EEC Cosmetics Directive 76/768/EEC, as amended, Annexes I through VII. Brussels: EEC.
37. Fitzhugh, O. G., P. J. Schouboe, and N. A. Nelson. 1960. Oral toxicities of lauric acid and certain lauric acid derivatives. Toxicol. Appl. Pharmacol. 2:59-67.
38. Food and Drug Administration (FDA). 1988. Memorandum dated June 27, 1998. Color additive petition no. 7T0130. Safety evaluation of substrata and precipitants used in the manufacture of color additive lakes. Washington, DC: FDA.
39. FDA. 1994a. Memorandum dated July 13, 1994. Safety evaluation of rosin in color additive lakes. Washington, DC: FDA.
40. FDA. 1994b. Memorandum dated August 22, 1994. Safety evaluation of dermal sensitization and photosensitization of rosinated lakes of D&C Red No. 6, D&C Red No. 7, and D&C Red No. 34. Washington, DC: FDA.
41. FDA. 1998. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
42. Fregert, S. 1981. Manual of contact dermatitis, 2nd ed., 71-81. Copenhagen: Munksgaard.
43. Gäfvert, E., L. P. Shao, A.-T. Karlberg, U. Nilsson, and J. L. G. Nilsson. 1994. Allergenicity of rosin (colophony) esters. II. Glyceryl monoabietate identified as contact allergen. Contact Dermatitis 28:229-234.
44. 2
45. 2
46. Gerrard, J. M., and G. Graff. 1980. 1-Arachidonyl-monoglyceride causes platelet aggregation: Indirect evidence for an acylglycerol acylhydrolase involvement in the release of arachidonic acid for prostaglandin synthesis. Prostaglandins Med. 4:419-430.
47. Giron, D., R. Link, and S. Bouissel. 1992. Analysis of mono-, di- and triglycerides in pharmaceutical excipients by capillary supercritical fluid chromatography. J. Pharm. Biomed. Anal. 10:821-830.
48. Hayakawa, R., K. Matsunaga, M. Suzuki, Y. Arima, and Y. Ohkido. 1987. Lipstick dermatitis due to C18 aliphatic compounds. Contact Dermatitis 16:215-219.
49. 2
50. 2
51. Holland, K. T., D. Taylor, and A. M. Farrell. 1994. The effect of glycerol monolaurate on growth of, and production of toxic shock syndrome toxin-1 and lipase by, Staphylococcus aureus. J. Antimicrob. Chemother. 33:41-55.
52. Huckle, W. R., and H. S. Earp. 1994. Regulation of cell proliferation and growth by angiotensin II. Prog. Growth Factor Res. 5:177-194.
53. 2
54. 2
55. 2
56. 2
57. 2
58. 2
59. 2
60. Informatics, Inc. 1973. GRAS (Generally Recognized as Safe) Food Ingredients - Glycerine and Glycerides. NTIS Report No. PB-221 227.
61. 2
62. 2
63. 2
64. 2
65. Jensen, P. A., and D.O'Brien. 1993. Industrial hygiene. In Aerosol measurement. Principles techniques and applications, eds. K. Willeke and P. A. Baron, 538-540. New York: John Wiley and Sons, Inc.
66. Kabara, J. J. 1984. Cosmetic and drug preservation. Principles and practice, 305-322, 618, 740. New York: Marcel Dekker.
67. Kabara, J. J., M. Ohkawa, T. Ikekawa, T. Katori, and N. Nishikawa. 1985. Examinations on antitumor, immunological, and plant-growth inhibitory effects of monoglycerides of caprylic, capric, and lauric acids and related compounds. Pharmacol. Eff. Lipids 13:263-272.
68. Karlberg, A. 1988. Contact allergy to colophony. (VII). Sensitizing studies with oxidation products of abietic and related acids. Acta Dermato-Venereal. Suppl. 139:1-46.
69. Kato, A., K. Ando, S. Suzuki, G. Tamura, and K. Arima. 1969. Antitumor activity of monoglycerides and other esters of fatty acids. J. Antibiot. 22:83-84.
70. Kato, A., K. Ando, G. Tamura, and K. Arima. 1971. Effects of some fatty acid esters on the viability and transplantability of Ehrlich ascites tumor cells. Cancer Res. 31:501-504.
71. Kimber, I., G. F. Gerberick, and D. A. Basketter. 1999. Thresholds in contact sensitization: Theoretical and practical considerations. Food Chem. Toxicol. 37:553-560.
72. Lee, M. W., and D. L. Severson. 1994. Signal transduction in vascular smooth muscle: Diacylglycerol second messengers and PKC action. Am. J. Physiol. 267:C659-C678.
73. Leo, A., C. Hansch, and D. Elkins. 1971. Partition coefficients and their uses. Chemical Rev. 71:525-616.
74. Lévy, L., V. Alvaro, C. Dubray, and D. Joubert. 1994. Ca(2+)-dependent protein kinase C isoforms in rat pituitary hyperplasia: effect of in vivo treatment with quinagolide. Eur. J. Pharmacol. 16:327-334.
75. Lewis, R. J., ed. 1993. Hawley's condensed chemical dictionary, 12th ed., 568, 1088, 1180. New York: Van Nostrand Reinhold.
76. Lide, D. R., and H. P. R. Frederikse, eds. 1993. CRC handbook of chemistry and physics. A ready reference book of chemical and physical data, 74th ed., 3-260-3-261, 3-502-3-504. Boca Raton: CRC Press.
77. Lyman, W. J., W. F. Reehl, and D. H. Rosenblatt. 1982. Handbook of chemical property estimation methods. New York: McGraw-Hill.
78. Maruyama, K., and C. Yonese. 1986. Separation and quantitative determination of monoacylglyceryol mixtures by reversed phase HPLC. J. Am. Oil Chem. Soc. 63:902-905.
79. Mattson, F. H., and R. A. Volpenhein. 1964. The digestion and absorption of triglycérides. J. Biol. Chem. 239:2772-2777.
80. 2
81. National Academy of Sciences (NAS). 1960. The safety of mono- and diglycerides for use as intentional additives in food (NAS publication no. 251). Washington, DC: NAS.
82. Niederpruem, H., H. Schweikert, J. W. Thueroff, and K. S. Zaenker. 1995. Inhibition of steroid 5 alpha-reductase activity by aliphatic fatty acids. Candidates for chemoprevention of prostate cancer. Ann. N. Y. Acad. Sci. 768:227-230.
83. Nomura, H., A. Katsuhiko, K. Sekiguchi, U. Kikkawa, and Y. Nishizuka. 1986. Biochem. Biophys. Res. Commun. 140:1143-1151.
84. Oh, D.-H., and D. L. Marshall. 1996. Monolaurin and acetic acid inactivation of Listeria monocytogenes attached to stainless steel. J. Food Protection 59:249-252.
85. Okumura, M., Y. Nakamori, Y. Yoshida, H. Niwa, and Y. Sugibayashi. 1990. Effect of monoglycerides on the percutaneous absorption of papaverine hydrochloride. Drug Des. Delivery 6:137-148.
86. Pepe, R. C., J. A. Wenninger, and G. N. McEwen, Jr., eds. 2002. International cosmetic ingredient dictionary and handbook, 9th ed. Washington, DC: CTFA.
87. Petschow, B. W., R. P. Batema, and L. L. Ford. 1996. Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids. Antimicrob. Agents Chemother. 40:302-306.
88. 2
89. Projan, S. J., S. Brown-Skrobot, P. M. Schlievert, G. Vandenesch, and R. P. Novick. 1994. Glycerol monolaurate inhibits the production of beta-lactamase, toxic shock toxin-1, and other staphylococcal exoproteins by interfering with signal transduction. J. Bacteriol. 176:204-209.
90. Rempe, J. M., and L. G. Santucci. 1997. CTFA list of Japanese cosmetic ingredients, 3rd ed. Washington, DC: CTFA.
91. Sánchez-Piñera, P., V. Micol, C. Corbalán-Garcia, and J. C. Gómez-Fernández. 1999. A comparative study of the activation of protein kinase C α by different diacylglycerol isomers. Biochem. J. 337:387-395.
92. Saffiotti, U., and P. Shubik. 1963. Studies on promoting action in skin carcino-genesis. Natl. Cancer Inst. Monogr. 10:489-507.
93. Schlievert, P. M., J. R. Deringer, M. H. Kim, S. J. Projan, and R. P. Novick. 1992. Effect of glycerol monolaurate on bacterial growth and toxin production. Antimicrob. Agents Chemother. 36:626-631.
94. Scientific & Technical Information Network (STN) International. 1997. Properties of esters of glycerin and lauric acid. Registry database file. Columbus, OH: STN International.
95. Shao, L. P., E. Gäfvert, A.-T. Karlberg, U. Nilsson, and J. L. G. Nillson. 1993. The allergenicity of glycerol esters and other esters of rosin (colophony). Contact Dermatitis 31:11-17.
96. 2
97. Takano, S., and Y. Kohdoh. 1987. Monoglyceride analysis with reversed phase HPLC. J. Am. Oil Chem. Soc. 64:1001-1003.
98. Tanaka, M., S. Shimizu, and S. Miyakawa. 1993. Contact dermatitis from glyceryl di-isostearate. Contact Dermatitis 29:41-42.
99. 2
100. 2
101. 2
102. 2
103. Witcher, K. J., R. P. Novick, and P. M. Schlievert. 1996. Modulation of immune cell proliferation by glycerol monolaurate. Clin. Diagn. Lab. Immunol. 3: 10-13.